HHSC to Participate in Cell and Gene Therapy Access Model, Beginning Sept. 1, 2025

Having trouble viewing this email? View it as a Web page. HHSC to Participate in Cell and Gene Therapy Access Model, Beginning Sept. 1, 2025 Beginning Sept. 1, 2025, Texas Medicaid will participate in the Cell and Gene Therapy (CGT) Access Model. Other News Change in PDL Status for Stimulants and Related Agents Drug Class, Effective Aug. 18, 2025 Change in PDL Status for Stimulants and Related Agents Drug Class, Effective Aug. 11, 2025 Temporary Non-preferred Drug Status to Start Sept. 1, 2025 Labor Day Holiday to Delay Pharmacy Payments (Sept. 1) Outreach and Training Reminder: Pharmacies Must Ensure Contact Information Is Current in PEMS VDP Provider Portal Registration, Training Information For pharmacies For prescribers Texas Health Steps Includes Pharmacy Education Opportunities

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to stevenmagallanes520.nims@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202